lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed and are posted here as part of a 12-month trial. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Tacrolimus Ameliorates Tubulointerstitial Inflammation in Diabetic Nephropathy via Inhibiting the NFATc1/TRPC6 Pathway

34 Pages Posted: 11 Jan 2020

See all articles by Shumin Zhang

Shumin Zhang

Central South University - Department of Nephrology

Huafen Wang

Central South University - Department of Nephrology

Yifei Liu

Central South University - Department of Nephrology

Wenxia Yang

Central South University - Department of Nephrology

Jialu Liu

Central South University - Department of Nephrology

Yuzhang Han

Central South University - Department of Nephrology

Yu Liu

Central South University - Department of Nephrology

Fuyou Liu

Central South University - Department of Nephrology

Lin Sun

Central South University - Department of Nephrology

Li Xiao

Central South University - Department of Nephrology

More...

Abstract

Background: Tubulointerstitial inflammation is crucial for the progression of diabetic nephropathy (DN), and tubular cells act as a driving force in the inflammatory cascade. Emerging data suggested that tacrolimus ameliorates podocyte injury and macrophage infiltration in STZ mice. However, the effect of tacrolimus on tubulointerstitial inflammation remains unknown.

Methods: Macrophage infiltration and expression of proinflammatory and fibrosis proteins were observed in the kidneys of db/db mice treated with tacrolimus. NFATc1 and TRPC6 expression were assayed and the correlation with tubulointerstitial inflammation was analyzed. To explore the effect and mechanism of tacrolimus, HK-2 cells were treated with tacrolimus with or without NFATc1 siRNA and TRPC6 plasmid under high glucose (HG) conditions.

Findings: Albuminuria and tubulointerstitial damage improved in db/db mice treated with tacrolimus. Macrophage inflitration and expression of IL-6, TNF-α, FN, Col-1 and cleaved-caspase 3 were inhibited. In addition, the expression of NFATc1 and TRPC6 was upregulated in the kidneys of DN patients, and correlated with tubular injury and inflammation. The expression of NFATc1 and TRPC6 also increased in the kidneys of db/db mice and HK-2 cells with HG, while tacrolimus inhibited these effects. HG-induced inflammatory markers and apoptosis were reversed by tacrolimus and NFATc1 siRNA in HK-2 cells, which was abolished by TRPC6 plasmid. Furthermore, HG-induced TRPC6 expression was inhibited by NFATc1 siRNA, while NFATc1 nuclear translocation was inhibited by tacrolimus, but was restored by TRPC6 plasmid in HK-2 cells under HG conditions.

Interpretation: These findings suggest that tacrolimus ameliorates tubulointerstitial inflammation in DN through NFATc1/TRPC6 feedback loop.

Funding Statement: This work was supported by the National Natural Science Foundation of China (81570658).

Declaration of Interests: The authors declare that there are no conflicts of interest.

Ethics Approval Statement: The human protocol was approved by the Ethics Committee of Second Xiangya Hospital, Central South University.

The Animal Care and Use Committee of Second Xiangya Hospital of Central South University approved all animal procedures.

Keywords: diabetic nephropathy, tubular cell, inflammation, tacrolimus, NFATc1, TRPC6

Suggested Citation

Zhang, Shumin and Wang, Huafen and Liu, Yifei and Yang, Wenxia and Liu, Jialu and Han, Yuzhang and Liu, Yu and Liu, Fuyou and Sun, Lin and Xiao, Li, Tacrolimus Ameliorates Tubulointerstitial Inflammation in Diabetic Nephropathy via Inhibiting the NFATc1/TRPC6 Pathway (January 6, 2020). Available at SSRN: https://ssrn.com/abstract=3514615 or http://dx.doi.org/10.2139/ssrn.3514615

Shumin Zhang

Central South University - Department of Nephrology

Hunan, 410011
China

Huafen Wang

Central South University - Department of Nephrology

Hunan, 410011
China

Yifei Liu

Central South University - Department of Nephrology

Hunan, 410011
China

Wenxia Yang

Central South University - Department of Nephrology

Hunan, 410011
China

Jialu Liu

Central South University - Department of Nephrology

Hunan, 410011
China

Yuzhang Han

Central South University - Department of Nephrology

Hunan, 410011
China

Yu Liu

Central South University - Department of Nephrology

Hunan, 410011
China

Fuyou Liu

Central South University - Department of Nephrology

Hunan, 410011
China

Lin Sun

Central South University - Department of Nephrology ( email )

Hunan, 410011
China

Li Xiao (Contact Author)

Central South University - Department of Nephrology ( email )

Hunan, 410011
China

Click here to go to TheLancet.com

Paper statistics

Abstract Views
73
Downloads
9